FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201216038> ?p ?o ?g. }

• W3201216038 abstract "Abstract Fingolimod and natalizumab are approved disease-modifying drugs in relapsing–remitting multiple sclerosis (RRMS). The two drugs have different modes of action and may therefore influence different aspects of MS-related tissue damage. In this retrospective cohort study, we longitudinally compared patients treated with fingolimod and patients treated with natalizumab by measures based on structural magnetic resonance imaging (MRI). We included patients with RRMS given that two standardized MRI scans under the same drug were available with an interval of at least 6 months both from therapy start to baseline scan and from baseline scan to follow-up scan. After matching for age, baseline and follow-up scans from 93 patients (fingolimod, 48; natalizumab, 45) were investigated. Mean follow-up time was 1.9 years. We determined the number of new white matter lesions as well as thalamic, cortical, and whole-brain atrophy. After scaling for time of the interscan interval, measures were analyzed by group comparisons and, to account for demographic and clinical characteristics, by multiple regression models and a binary logistic regression model. Compared to natalizumab, fingolimod treatment went along with more new white matter lesions (median [interquartile range, IQR] 0.0 [0.0; 0.7] vs. 0.0 [0.0; 0.0] /year; p < 0.01) whereas whole-brain atrophy was lower (median [IQR] 0.2 [0.0; 0.5] vs. 0.5 [0.2; 1.0] %/year; p = 0.01). These significant differences were confirmed by multiple regression models and the binary logistic regression model. In conclusion, our observation is compatible with stronger neuroprotective properties of fingolimod compared to natalizumab." @default.
• W3201216038 created "2021-09-27" @default.
• W3201216038 creator A5003938965 @default.
• W3201216038 creator A5018300417 @default.
• W3201216038 creator A5022050597 @default.
• W3201216038 creator A5023893355 @default.
• W3201216038 creator A5028243672 @default.
• W3201216038 creator A5038501763 @default.
• W3201216038 creator A5049197829 @default.
• W3201216038 creator A5071180146 @default.
• W3201216038 creator A5085312364 @default.
• W3201216038 creator A5085380763 @default.
• W3201216038 date "2021-09-24" @default.
• W3201216038 modified "2023-10-14" @default.
• W3201216038 title "Differential Effects of Fingolimod and Natalizumab on Magnetic Resonance Imaging Measures in Relapsing–Remitting Multiple Sclerosis" @default.
• W3201216038 cites W1970603031 @default.
• W3201216038 cites W1984208566 @default.
• W3201216038 cites W1994083593 @default.
• W3201216038 cites W1999522048 @default.
• W3201216038 cites W2102345898 @default.
• W3201216038 cites W2103758700 @default.
• W3201216038 cites W2104948944 @default.
• W3201216038 cites W2116135717 @default.
• W3201216038 cites W2118735809 @default.
• W3201216038 cites W2127712005 @default.
• W3201216038 cites W2148563799 @default.
• W3201216038 cites W2151340435 @default.
• W3201216038 cites W2157401887 @default.
• W3201216038 cites W2164556363 @default.
• W3201216038 cites W2298502938 @default.
• W3201216038 cites W2304087016 @default.
• W3201216038 cites W2468275093 @default.
• W3201216038 cites W2479403025 @default.
• W3201216038 cites W2524779870 @default.
• W3201216038 cites W2594840221 @default.
• W3201216038 cites W2741497413 @default.
• W3201216038 cites W2777074421 @default.
• W3201216038 cites W2897587086 @default.
• W3201216038 cites W2902325621 @default.
• W3201216038 cites W2906066137 @default.
• W3201216038 cites W2907323195 @default.
• W3201216038 cites W2963176192 @default.
• W3201216038 cites W2964883388 @default.
• W3201216038 cites W2970521249 @default.
• W3201216038 cites W3008223946 @default.
• W3201216038 cites W3039128139 @default.
• W3201216038 cites W3093926168 @default.
• W3201216038 cites W3112364762 @default.
• W3201216038 cites W3121899751 @default.
• W3201216038 cites W3131957723 @default.
• W3201216038 cites W3186959327 @default.
• W3201216038 cites W4253381763 @default.
• W3201216038 doi "https://doi.org/10.1007/s13311-021-01118-2" @default.
• W3201216038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34561843" @default.
• W3201216038 hasPublicationYear "2021" @default.
• W3201216038 type Work @default.
• W3201216038 sameAs 3201216038 @default.
• W3201216038 citedByCount "0" @default.
• W3201216038 crossrefType "journal-article" @default.
• W3201216038 hasAuthorship W3201216038A5003938965 @default.
• W3201216038 hasAuthorship W3201216038A5018300417 @default.
• W3201216038 hasAuthorship W3201216038A5022050597 @default.
• W3201216038 hasAuthorship W3201216038A5023893355 @default.
• W3201216038 hasAuthorship W3201216038A5028243672 @default.
• W3201216038 hasAuthorship W3201216038A5038501763 @default.
• W3201216038 hasAuthorship W3201216038A5049197829 @default.
• W3201216038 hasAuthorship W3201216038A5071180146 @default.
• W3201216038 hasAuthorship W3201216038A5085312364 @default.
• W3201216038 hasAuthorship W3201216038A5085380763 @default.
• W3201216038 hasBestOaLocation W32012160381 @default.
• W3201216038 hasConcept C118552586 @default.
• W3201216038 hasConcept C119060515 @default.
• W3201216038 hasConcept C126322002 @default.
• W3201216038 hasConcept C126838900 @default.
• W3201216038 hasConcept C143409427 @default.
• W3201216038 hasConcept C151956035 @default.
• W3201216038 hasConcept C16568411 @default.
• W3201216038 hasConcept C203014093 @default.
• W3201216038 hasConcept C2776036978 @default.
• W3201216038 hasConcept C2776819417 @default.
• W3201216038 hasConcept C2779889316 @default.
• W3201216038 hasConcept C2780640218 @default.
• W3201216038 hasConcept C2781004633 @default.
• W3201216038 hasConcept C2781172350 @default.
• W3201216038 hasConcept C2781192897 @default.
• W3201216038 hasConcept C2989005 @default.
• W3201216038 hasConcept C3020694758 @default.
• W3201216038 hasConcept C71924100 @default.
• W3201216038 hasConcept C72563966 @default.
• W3201216038 hasConceptScore W3201216038C118552586 @default.
• W3201216038 hasConceptScore W3201216038C119060515 @default.
• W3201216038 hasConceptScore W3201216038C126322002 @default.
• W3201216038 hasConceptScore W3201216038C126838900 @default.
• W3201216038 hasConceptScore W3201216038C143409427 @default.
• W3201216038 hasConceptScore W3201216038C151956035 @default.
• W3201216038 hasConceptScore W3201216038C16568411 @default.
• W3201216038 hasConceptScore W3201216038C203014093 @default.
• W3201216038 hasConceptScore W3201216038C2776036978 @default.
• W3201216038 hasConceptScore W3201216038C2776819417 @default.
• W3201216038 hasConceptScore W3201216038C2779889316 @default.

• next